In addition, setting the value at, say, 0.3 seems unreasonably high, as this is consistently well into the range of frailty, however, defined (including by an increased hazard) so would be insensitive.
Frailty will be assessed with the Canadian Study of Health and Aging (CSHA Clinical Frailty Scaleale [ 3] and the Frailty Index SHARE FI [ 33, 34]: The CSHA-Clinical Frailty Scale stratifies patients according to simple clinical characteristics; it captures a wide range of frailty features and shows a good performance in assessing risk of death [ 3].
The characteristics (distributions, means, and ranges) of the frailty and social vulnerability indices were compared and correlations calculated.
In the general population, there is a widespread range in the prevalence of frailty ranging from 33 to 88%% [ 39].
The association between hospitalisation within 28 days of CAP diagnosis (a 'post-CAP' hospitalisation) and a wide range of comorbidities, frailty factors, medications and vaccinations.
The prevalence of frailty ranges from 10% to 60%, depending on the CVD burden, as well as the tool and cutoff chosen to define frailty.
The worldwide prevalence of frailty ranges between 6.9 % and 42.6 % [ 10, 13– 17].
We examined a wide range of potential correlates of frailty covering social, psychological, environmental, and health-related factors.
Collard et al. reported widely differing prevalences of frailty, ranging between 4.0% and 59.1% in community-dwelling elderly adults, with an overall weighted prevalence of 10.7% for frailty and 41.6% for prefrailty [ 5].
The results of this study present the association of frailty with a range of vascular factors in older men with and without established CVD.
